Skip Navigation
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer

Association List

[Full Text]
Displaying Investigations 1 to 32 of 32 found
From 7 References


Asmann et al 2012, Cancer Res
  Adenocarcinoma Breast
ELAC1/SMAD4
t(18;18)(q21;q21)

Frattini et al 2013, Nat Genet
  Astrocytoma, grade III-IV/Glioblastoma Brain
SMAD4/RAX
t(18;18)(q21;q21)

Holmfeldt et al 2013, Nat Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
SMAD2/ZBTB7C
t(18;18)(q21;q21)
B-Lineage

Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Oesophagus
ACAA2/MYO5B
t(18;18)(q21;q21)
  Adenocarcinoma Large intestine
ATP5A1/HAUS1
t(18;18)(q21;q21)
  Adenocarcinoma Liver
CTIF/KATNAL2
t(18;18)(q21;q21)
  Adenocarcinoma Prostate
DYM/ACAA2
t(18;18)(q21;q21)
  Adenocarcinoma Prostate
DYM/KATNAL2
t(18;18)(q21;q21)
  Adenocarcinoma Pancreas
DYM/C18orf32
t(18;18)(q21;q21)
  Mesenchymal tumor, NOS Unknown site
DYM/CFAP53
t(18;18)(q21;q21)
  Adenocarcinoma Stomach
ELAC1/MRO
t(18;18)(q21;q21)
  Squamous cell carcinoma Lung
MYO5B/MBD1
t(18;18)(q21;q21)
  Transitional cell carcinoma Bladder
MYO5B/DCC
t(18;18)(q21;q21)
  Adenocarcinoma Stomach
NEDD4L/ALPK2
t(18;18)(q21;q21)
  Transitional cell carcinoma Bladder
RAB27B/WDR7
t(18;18)(q21;q21)
  Mesenchymal tumor, NOS Unknown site
RNF165/PHLPP1
t(18;18)(q21;q21)
  Mesenchymal tumor, NOS Unknown site
SMAD7/CTIF
t(18;18)(q21;q21)
  Squamous cell carcinoma Lung
ZNF532/MALT1
t(18;18)(q21;q21)

Kloosterman et al 2017, Cancer Res
  Adenocarcinoma Large intestine
NEDD4L/SERPINB5
t(18;18)(q21;q21)

Pintarelli et al 2016, Oncotarget
  Nonneoplastic epithelial disorder/lesion Lung
MBD1/CFAP53
t(18;18)(q21;q21)

Yoshihara et al 2015, Oncogene
  Squamous cell carcinoma Lung
EPG5/ST8SIA5
t(18;18)(q21;q21)
  Squamous cell carcinoma Lung
CTIF/PSTPIP2
t(18;18)(q21;q21)
  Squamous cell carcinoma Oral cavity
RNF152/PIGN
t(18;18)(q21;q21)
  Adenocarcinoma Breast
NEDD4L/BCL2
t(18;18)(q21;q21)
  Adenocarcinoma Breast
DYM/CTIF
t(18;18)(q21;q21)
  Adenocarcinoma Breast
MYO5B/DYM
t(18;18)(q21;q21)
  Adenocarcinoma Breast
SMAD7/DYM
t(18;18)(q21;q21)
  Adenocarcinoma Breast
TNFRSF11A/KIAA1468
t(18;18)(q21;q21)
  Adenocarcinoma Breast
DYM/MYO5B
t(18;18)(q21;q21)
  Adenocarcinoma Breast
SMAD2/ZBTB7C
t(18;18)(q21;q21)
  Adenocarcinoma Breast
CTIF/SMAD2
t(18;18)(q21;q21)
  Transitional cell carcinoma Bladder
MYO5B/CFAP53
t(18;18)(q21;q21)